Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice

Cancer Research

Volumn 70, Issue 20, 2010, Pages 7938-7948

  De Andrea, Marco ^a,b   Rittà, Massimo ^a,b   Landini, Manuela M ^b   Borgogna, Cinzia ^b   Mondini, Michele ^b   Kern, Florian ^c   Ehrenreiter, Karin ^c   Baccarini, Manuela ^c   Marcuzzi, Gian Paolo ^d   Smola, Sigrun ^d,e   Pfister, Herbert ^d   Landolfo, Santo ^a   Gariglio, Marisa ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Amedeo Avogadro University   (Italy)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF COLOGNE   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STAT3 PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EPIDERMIS; GENE TARGETING; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HUMAN PAPILLOMAVIRUS TYPE 8; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSGENIC MOUSE; VIRUS STRAIN; WART VIRUS; WILD TYPE;

ANIMALS; CELL MOVEMENT; FORESKIN; HETEROZYGOTE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; INTEGRIN ALPHA6BETA1; KERATINOCYTES; MALE; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; REPRESSOR PROTEINS; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR;

EID: 78049281397     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-1128     Document Type: Article

References (35)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
2. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006;208:152-64.
3. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009;384:260-5.
4. Akgul B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol 2006;208:165-75.
5. Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis Markers 2007;23:247-59. (Pubitemid 47015794)
6. Zavattaro E, Azzimonti B, Mondini M, et al. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol 2008;128:732-5. (Pubitemid 351252678)
7. Dell'oste V, Azzimonti B, De Andrea M, et al. High β-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 2009;129:1026-34.
8. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC. β-Papillomavirus infection and skin cancer. J Invest Dermatol 2008;128:1355-8.
9. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003:52-6.
10. Schaper ID, Marcuzzi GP, Weissenborn SJ, et al. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 2005;65:1394-400.
11. Pfefferle R, Marcuzzi GP, Akgul B, et al. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Invest Dermatol 2008;128:2310-5.
12. Marcuzzi GP, Hufbauer M, Kasper HU, Weissenborn SJ, Smola S, Pfister H. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 2009;90:2855-64.
13. Dong W, Kloz U, Accardi R, et al. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J Virol 2005;79:14899-908. (Pubitemid 41636287)
14. Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers EM. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 2006;80:11153-64. (Pubitemid 44706555)
15. Zhong Z, Wen Z, Darnell JE, Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;264:95-8. (Pubitemid 24144493)
16. Levy DE, Darnell JE, Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-62.
17. Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 2009;1171:59-76.
18. Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997;94:3801-4. (Pubitemid 27180453)
19. Sano S, Itami S, Takeda K, et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 1999;18:4657-68. (Pubitemid 29415520)
20. Chan KS, Sano S, Kiguchi K, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004;114:720-8. (Pubitemid 39578762)
21. Sano S, Chan KS, Kira M, et al. Signal transducer and activator of transcription 3 is a key regulator of keratinocyte survival and proliferation following UV irradiation. Cancer Res 2005;65:5720-9. (Pubitemid 40911175)
22. Chan KS, Sano S, Kataoka K, et al. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis. Oncogene 2008;27:1087-94. (Pubitemid 351253189)
23. Kataoka K, Kim DJ, Carbajal S, Clifford JL, DiGiovanni J. Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis 2008;29:1108-14. (Pubitemid 351958688)
24. Kim DJ, Angel JM, Sano S, DiGiovanni J. Constitutive activation and targeted disruption of signal transducer and activator of transcription 3 (Stat3) in mouse epidermis reveal its critical role in UVB-induced skin carcinogenesis. Oncogene 2009;28:950-60.
25. Tarutani M, Itami S, Okabe M, et al. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci U S A 1997;94:7400-5. (Pubitemid 27345327)
26. Ehrenreiter K, Piazzolla D, Velamoor V, et al. Raf-1 regulates Rho signaling and cell migration. J Cell Biol 2005;168:955-64. (Pubitemid 40397009)
27. Chiarle R, Simmons WJ, Cai H, et al. Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med 2005;11:623-9. (Pubitemid 40868302)
28. Fuchs E. Keratins and the skin. Annu Rev Cell Dev Biol 1995;11:123-53.
29. Byrne C, Fuchs E. Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol Cell Biol 1993;13:3176-90. (Pubitemid 23157256)
30. Ramirez A, Bravo A, Jorcano JL, Vidal M. Sequences 5′ of the bovine keratin 5 gene direct tissue- and cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 1994;58:53-64. (Pubitemid 24361127)
31. Yin W, Cheepala S, Roberts JN, Syson-Chan K, DiGiovanni J, Clifford JL. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol Cancer 2006;5:15. (Pubitemid 44069692)
32. Santarosa M, Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004;1654:105-22. (Pubitemid 38681204)
33. McKusick VA. OMIM™: Online Mendelian Inheritance in Man. Available from: http://www.ncbi.nlm.nih.gov/Omim/.
34. Seidman JG, Seidman C. Transcription factor haploinsufficiency: when half a loaf is not enough. J Clin Invest 2002;109:451-5. (Pubitemid 34171775)
35. Bollrath J, Phesse TJ, von Burstin VA, et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 2009;15:91-102.